高级检索
    杨学宁, 吴一龙. 伊立替康加顺铂:有望成为广泛期小细胞肺癌一线治疗的新标准[J]. 循证医学, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
    引用本文: 杨学宁, 吴一龙. 伊立替康加顺铂:有望成为广泛期小细胞肺癌一线治疗的新标准[J]. 循证医学, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
    shu
    Irinotecan plus Cisplatin:new standard for first-line treatment of extensive small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
    Citation: Irinotecan plus Cisplatin:new standard for first-line treatment of extensive small-cell lung cancer[J]. Journal of Evidence-Based Medicine, 2003, 3(2): 106-107. DOI: 10.3969/j.issn.1671-5144.2003.02.015
    shu

    伊立替康加顺铂:有望成为广泛期小细胞肺癌一线治疗的新标准

    Irinotecan plus Cisplatin:new standard for first-line treatment of extensive small-cell lung cancer

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回